ReviewFrontiers in cardiovascular medicine2024
Contemporary approach to cardiogenic shock care: a state-of-the-art review.
Review in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- Cardiogenic shock and acute renal failure associated mortality trends in the United States: a retrospective analysis of death records from 1999 to 2023.BMC cardiovascular disorders · 2026Article
- Contemporary Mechanical Support Devices for Temporary and Long-Term Applications.Bioengineering (Basel, Switzerland) · 2026Review
- Cardiogenic Shock Management in the Modern Era: A Narrative Review of Percutaneous Mechanical Circulatory Support Devices.Journal of cardiovascular development and disease · 2025Review
- Development and validation of a machine learning model for predicting mortality risk in veno-arterial extracorporeal membrane oxygenation patients.Scientific reports · 2025Article
- From Struggle to Triumph: A Journey Through SCAI Stages to Myocardial Recovery.JACC. Case reports · 2025Article
- Cardiogenic Shock Due to Progressive Heart Failure-Clinical Characteristics and Outcomes Compared to Other Aetiologies.Biomedicines · 2025Article
- Global Trends in Extracorporeal Membrane Oxygenation Support for Circulatory Failure: A Bibliometric Analysis.Healthcare (Basel, Switzerland) · 2025Review
- AI-Based Predictive Models for Cardiogenic Shock in STEMI: Real-World Data for Early Risk Assessment and Prognostic Insights.Journal of clinical medicine · 2025Article
- Dynamic Predictive Models of Cardiogenic Shock in STEMI: Focus on Interventional and Critical Care Phases.Journal of clinical medicine · 2025Article
- Comment: Acute Myocardial Infarction and Stage E Shock: Insights From the RECOVER III Study.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- Managing the acute cardiac functional crisis: a comprehensive review of cardiogenic shock management strategies.European heart journal supplements : journal of the European Society of Cardiology · 2025Article
- The current use of vasoactive agents in cardiogenic shock related to myocardial infarction and acute decompensated heart failure.American heart journal plus : cardiology research and practice · 2025Article
- Clinical Review of Cardiogenic Shock After Acute Myocardial Infarction - Revascularization, Mechanical Circulatory Support, and Beyond.Circulation reports · 2025Review
- Cardiogenic Shock in Restrictive Cardiomyopathies: What We Know So Far.US cardiology · 2025Review
- Case Report: Intra-aortic balloon pump in a patient with refractory cardiogenic shock complicating severe aortic stenosis-enhanced hemodynamic response with low aortic compliance.Frontiers in cardiovascular medicine · 2025Article
- The Price We Pay for Progression in Shock Care: Economic Burden, Accessibility, and Adoption of Shock-Teams and Mechanical Circulatory Support Devices.Current cardiology reports · 2024Review
- The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A Narrative Review.Biomedicines · 2024Review
- Embracing innovation and advancing care: integrating learning health system principles into Inova Schar Heart and Vascular.Frontiers in cardiovascular medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS continues to maintain high morbidity and mortality ranging from 35 to 50%. More recently, burgeoning observational research in this field aimed at enhancing the early recognition and characterization of the shock state through standardized team-based protocols, comprehensive hemodynamic profiling, and tailored and selective utilization of temporary mechanical circulatory support devices has been associated with improved outcomes. In this narrative review, we discuss the pathophysiology of CS, novel phenotypes, evolving definitions and staging systems, currently available pharmacologic and device-based therapies, standardized, team-based management protocols, and regionalized systems-of-care aimed at improving shock outcomes. We also explore opportunities for fertile investigation through randomized and non-randomized studies to address the prevailing knowledge gaps that will be critical to improving long-term outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.